Dr. Stiff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
395 W 12th Ave
Fl 3
Columbus, OH 43210Phone+1 614-293-3989Fax+1 614-293-9789
Education & Training
Ohio State University College of MedicineClass of 2015
Certifications & Licensure
OH State Medical License 2019 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 54 citationsModeling combination therapy for breast cancer with BET and immune checkpoint inhibitorsXiulan Lai, Andrew Stiff, Megan C. Duggan, Robert Wesolowski, William E. Carson
Proceedings of the National Academy of Sciences of the United States of America. 2018-05-22 - 26 citationsHDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomideAlessandro Canella, Hector Cordero Nieves, Douglas W. Sborov, Luciano Cascione, Hanna S. Radomska
Oncotarget. 2015-09-28 - 153 citationsNitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function.Andrew Stiff, Prashant Trikha, Bethany L. Mundy-Bosse, Elizabeth L. McMichael, Thomas A. Mace
Clinical Cancer Research. 2018-04-15
Journal Articles
- Modeling Combination Therapy for Breast Cancer with BET and Immune Checkpoint InhibitorsRobert Wesolowski, Andrew Stiff, Proceedings of the National Academy of Sciences
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
